Company: VERA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-314244
Chunk: 58

Company: Vera Therapeutics, Inc.
Filing Date: 2025-12-10
Form: 424B5
Chunk 58
---
 for dividends; |

| • |     | whether dividends will be cumulative or non-cumulative and, if 
 cumulative, the date from which dividends will accumulate;     |

| • |     | the procedures for any auction and remarketing, if any; |

| • |     | the provision for a sinking fund, if any; |

| • |     | the provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those 
 redemption and repurchase rights;                                                                                 |

| • |     | any listing of the preferred stock on any securities exchange or market; |

12

| • |     | whether the preferred stock will be convertible into our Class A or Class B common stock, and, if 
 applicable, the conversion price, or how it will be calculated, and the conversion period;        |

| • |     | whether the preferred stock will be exchangeable into debt securities, and, if applicable, the exchange price, or 
 how it will be calculated, and the exchange period;                                                               |

| • |     | voting rights, if any, of the preferred stock; |

| • |     | preemptive rights, if any; |

| • |     | restrictions on transfer, sale or other assignment, if any; |

| • |     | whether interests in the preferred stock will be represented by depositary shares; |

| • |     | a discussion of any material United States federal income tax considerations applicable to the preferred stock; |

| • |     | the relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, 
 dissolve or wind up our affairs;                                                                              |

| • |     | any limitations on issuance of any class or series of preferred stock ranking senior to or on a parity with the  
 series of preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and |

| • |     | any other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock. |

When we issue shares of preferred stock under this prospectus, the shares will be fully paid and nonassessable and will not have, or be subject to, any preemptive or similar rights. Anti-Takeover Provisions The provisions of Delaware law, our amended and restated certificate of incorporation and our amended and restated bylaws, which are summarized below, may have the effect of delaying, deferring or discouraging another person from acquiring control of our company. They are also